Financial news, markets, and business updates
Dr. Jeremy Faust, a Boston emergency physician, uses his platform to blend urgent medical insights with broader health discussions, attracting a large audience.
The sharp rise in ACA marketplace premium costs significantly affects small businesses, raising new challenges in employee health benefits.
A father invests $70 million into developing a gene therapy for his daughter’s rare condition, seeking breakthroughs for patients like her.
The search for the next FDA commissioner heats up with notable contenders, while AstraZeneca's heart drug faces a major trial setback.
Recent studies suggest that psilocybin therapy may offer enduring relief for patients with depression, presenting a significant advancement in treatment options.
The decline of employer-based health insurance is straining workers and businesses, raising serious concerns about its sustainability.
Vertex Pharmaceuticals is set to acquire Crinetics Pharmaceuticals for $10 billion, marking a pivotal expansion into rare disease treatments.
Soaring health insurance expenses are pushing small businesses to abandon employee health coverage, challenging America's employer-based system.
With rising expenses, small companies are increasingly unable to provide health insurance, impacting millions of American workers and their families.
The current Ebola outbreak in the DRC faces severe obstacles to containment, risking a permanent endemic situation that could have global repercussions.
Medicare plans to reduce payments for 340B drugs by over 33%, a move criticized for potentially harming safety-net hospitals while benefiting for-profits.
A recent court ruling benefits Amgen, blocking a price cap on Enbrel, while Medicare expands access to obesity medications for older Americans.
The biotech sector has experienced a remarkable rise in performance, with major indices celebrating significant gains as the year progresses.
After a distressing buyout, Bluebird Bio's transformation into Genetix positions it to lead the market in sickle cell gene therapies by 2030.
UpDoc's FDA-cleared app integrates large language models to assist diabetes management, sparking conversations about AI's role in patient care.
A recent study highlights that older adults with obesity are achieving better cardiovascular health metrics, potentially due to increased use of statins and blood pressure drugs.
Anthropic launches Claude Science to aid pharmaceutical research, while Trump's drug pricing plans face hurdles with mid-sized companies.
Zyn's nicotine pouch marketing is approved by the FDA, claiming lower risks compared to cigarettes, prompting concern among health advocates.
A recent revelation exposes the alcohol industry's significant financial influence on public health organizations, impacting cancer prevention messaging.
Current diagnostic strategies for Ebola and Marburg viruses fail to adapt to the complexities of overlapping outbreaks, highlighting urgent needs in public health.